Canadian Agency for Drugs and Technologies in Health. (2016). Pharmacoeconomic review report Emtricitabine/tenofovir alafenamide (Descovy). Canadian Agency for Drugs and Technologies in Health.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Emtricitabine/tenofovir Alafenamide (Descovy). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2016.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Emtricitabine/tenofovir Alafenamide (Descovy). Canadian Agency for Drugs and Technologies in Health, 2016.
Warning: These citations may not always be 100% accurate.